Risk factors for need of reoperation in bilateral chronic subdural haematomas

Shaian Zolfaghari1, Jiri Bartek2,3,4, Felix Djärf5

  • 1Department of Neurosurgery, Institution of Clinical Sciences, Lund University, Lund, Sweden. Shaian.zolfaghari@med.lu.se.

Acta Neurochirurgica
|April 2, 2021
PubMed

Insights

Upfront bilateral evacuation of bilateral chronic subdural haematoma (bCSDH) is linked to a lower reoperation risk compared to unilateral evacuation. This finding suggests a need for revised treatment guidelines for bCSDH management.

Area of Science:

  • Neurosurgery
  • Neurology
  • Surgical Outcomes

Background:

  • Bilateral chronic subdural haematoma (bCSDH) is a common neurosurgical condition.
  • bCSDH accounts for 20-25% of chronic subdural haematoma (CSDH) cases and has a higher recurrence rate.
  • Current treatment strategies for bCSDH lack a clear consensus regarding unilateral versus bilateral evacuation.

Purpose of the Study:

  • To investigate risk factors associated with reoperation in patients diagnosed with bCSDH.
  • To compare reoperation rates between unilateral and bilateral evacuation approaches for bCSDH.

Main Methods:

  • A retrospective cohort study included 326 patients with radiological evidence of bCSDH.
  • Patients were categorized into primary unilateral (n=193) or bilateral (n=133) evacuation groups.
  • Reoperation within 3 months was the primary outcome, analyzed using multivariable logistic regression.

Main Results:

  • The overall reoperation rate was 26.4%.
  • Unilateral evacuation had a significantly higher reoperation rate (32.1%) compared to bilateral evacuation (18.0%, p=0.005).
  • Unilateral evacuation (OR 1.91) and complications (OR 2.20) were identified as risk factors for reoperation.

Conclusions:

  • Unilateral evacuation of bCSDH is associated with an increased risk of reoperation compared to upfront bilateral evacuation.
  • The study highlights the need for further discussion on surgical criteria for bCSDH, given differing center practices.
  • Standardizing treatment approaches for bCSDH may improve patient outcomes and reduce reoperation rates.
Abstract

Related Concept Videos